25. Isla
ISLA
The Archive smells like solder and cold coffee. Ezra has three versions of the same logistics tree open across three screens, each arranged according to a logic I understand only after he explains it twice.
Raphael replaced his coffee with decaf yesterday. Ezra noticed on the first sip and drank it anyway, which is how I know their conversation was serious.
Theon and I spoke to him the morning after the isolation suite, with Raphael present and no one else. Ezra admitted to the tremor and to sleeping less than three hours a night. He accepted the reduced overnight workload. He did not explain what started either problem, and none of us forced him.
Today his hands are steadier. Not still. Ezra’s hands are never still.
The western hub has a name now. Ezra pulled it out of a refrigerated-freight account two days ago—Seattle, hiding the way all of them hide, inside a company that sounds like nothing. The last blank space on the map has a city in it.
“Seattle’s synthesis logs,” he says without turning from the center screen. “Cross-reference them against the shipping manifests you flagged Tuesday.”
“I already did that Tuesday.”
“Different question.”
He finally looks at me. I wait.
“Where does the material actually originate?” he asks.
I return to the manifests.
The Seattle hub lists a distributor outside Tacoma as the vendor for one of its V-series intermediates. That was as far as I followed it the first time. Now I move backward through lot certificates, freight consolidations, and invoices split among three shell companies.
The same manufacturer appears beneath all of them.
“One producer,” I say. “Not just one distributor.”
Ezra says nothing.
I keep digging.
It takes eleven minutes to reach the bottom layer. The shell structure is almost elegant—good enough to survive an ordinary financial audit, not good enough to survive someone trained to build the same camouflage.
“Cascade Analytical Supply,” I say. “Actual plant in rural Texas. Registered as an agricultural-testing laboratory. The Tacoma address is only a distribution conduit.”
I send the corporate tree to his middle screen.
“Cascade manufactures the chlorinated intermediate. Seattle’s distributor relabels and forwards it. Six other U.S. facilities receive lots from the same Texas plant.”
Ezra stops moving.
“Single-source dependency,” he says.
“Across seven facilities.”
His model begins to change. Customer nodes expand beneath Cascade. Freight accounts connect to addresses we have seen but not yet validated. Two of the western hub’s four unidentified distribution points appear in the tree.
My pulse climbs.
“If Cascade’s records are complete,” I say, “the supplier may identify facilities we haven’t found through the hubs.”
“And give us a second way to verify every destination it shares with Seattle.”
For a moment, the obvious destructive answer hangs between us: stop the precursor, stop seven facilities.
Neither of us says it.
The children at those facilities are dependent on the compounds the precursor becomes. Removing the supply before medical teams reach them would turn a network vulnerability into a mass withdrawal event.
“We cannot take it offline,” I say.
“No.” Ezra marks the supplier node in amber rather than red. “It is not a kill switch. It is an observatory.”
I look at him.
“Access the customer records,” he continues. “Maintain the production schedule. Watch every shipment until recovery teams are ready for the facilities on the other end.”
The cold excitement under my sternum changes shape. Not destruction. Visibility.
“Get Nikolai,” I say.
“Already did.”
Of course he did.
The Chamber fills twenty minutes later.
I stand beside Ezra’s display with a paper folder I do not need. Theon takes the place on my right, close enough that the back of his hand brushes mine.
Nikolai reads the header before everyone sits. “Cascade Analytical Supply. Explain.”
I explain the Tacoma distributor, the Texas manufacturer, and the seven confirmed customers. Ezra adds the overlap with the western hub’s unknown distribution points.
“What does taking Cascade offline do to active dosing?” Nikolai asks.
“Nothing good,” I say. “Working stock varies by facility, but some could begin running short within weeks. We do not interrupt production or shipping.”
Raphael nods once.
“Objective?” Damon asks.
“Quiet access,” Ezra says. “Clone the customer and batch records, establish persistence if possible, verify the precursor identity, and leave the plant operating normally.”
“Security footprint?” Nikolai asks.
I bring up the property file. “The visible footprint is small. Eleven employees on payroll, commercial locks, no declared security contract, no recent permit activity suggesting hardening.”
“Visible,” Damon repeats.
“Yes.” I meet his eyes. “That does not make the threat small. It means we need current surveillance before we decide what is behind the cover.”
His attention stays on me for another second. “Good.”
Marcus pulls the address onto his screen. “I can have remote imaging and a seventy-two-hour movement pattern by tomorrow. We will still need eyes on the ground.”
“Dominic,” Nikolai says.
Dominic gives a short nod. “I can enter under the agricultural cover. Equipment-service contractor or compliance auditor, depending on which credential survives scrutiny.”
“No approach until Marcus confirms the staff pattern,” Damon says. “No assumption that undeclared security means no security.”
“Agreed,” Nikolai says.
The Seattle schematic opens beside Cascade.
The unnamed western hub has a name now. Seattle, Washington. It has spent years hiding inside a biomedical-storage company near the industrial south end, moving controlled lots through ordinary refrigerated freight.
“Forty-two children confirmed,” Marcus says. “Six additional files may be duplicates or unregistered residents. We plan capacity for forty-eight. Ages six through sixteen. Sixty-one staff on the current rotation, with armed security on both residential levels.”
Lucien looks up. “How many under eight?”
“At least nine.”
“Some will not walk with masked personnel,” he says. “Some will not tolerate being carried. I need unmasked clinical staff inside the first secure zone and transport teams prepared for children who freeze rather than move.”
Raphael adds it to his list. “Four transports minimum, likely five. Two clinicians per vehicle and a spare medication team at staging.”
“I can build provisional stabilization grids from the pharmacy manifests,” I say. “Not full tapers. Those need bloodwork and examination after extraction. But we can identify dangerous interruptions, likely interactions, and which stock has to leave with each child.”
Theon glances at me, approval warming the ice of his expression.
“How soon do you have the pharmacy data?” Raphael asks.
“Partial access now. If Cascade carries customer-specific batch specifications, the Texas operation may fill the gaps.”
“Then Seattle does not proceed without those records,” Nikolai says.
“Agreed,” Raphael and I answer together.
He looks between us, then continues.
“Cascade first. Intelligence access only. Seattle follows seventy-two hours later if Cascade remains unaware and the recovered data supports the plan. If the supplier access is detected, Seattle aborts and we rebuild.”
Ezra replaces the single countdown with two linked gates. Three days to Cascade. Six to Seattle.
“Cascade team,” Nikolai says. “Dominic handles cover and physical access. Theon verifies the chemical and production records. Isla identifies customer documentation and chain-of-custody structure. A local reserve holds outside the perimeter.”
Theon’s hand stills beside mine.
“Assignment remains provisional until Marcus finishes surveillance and Damon approves the entry conditions,” Nikolai adds. “If the site is not what the cover claims, the team does not improvise a breach.”
“Understood,” I say.
Nikolai looks at Theon. “Objection?”
“The assignment is logical.”
“That was not the question.”
Theon’s jaw works once. “I object to every building she enters. I do not object to the role as currently defined.”
Honest. Possessive. Operationally usable.
Under the table, his fingers find mine. The pressure is firm, not painful.
“Seattle,” Nikolai continues. “Damon and Darius lead entry. Lucien and Raphael coordinate the children and clinical crews. Marcus and Ezra remain remote. Final personnel assignments after the Cascade gate.”
“Korte?” Darius asks.
“Still unconfirmed,” Marcus says. “Part of her security detail entered Washington yesterday. We do not know whether she traveled with them.”
Theon’s thumb moves once across my knuckle.
“Chemical hazard at Cascade,” Raphael says. “What exactly are they producing?”
“The records use an internal code,” I tell him. “The structure attached to the Seattle certificate is incomplete. We know it is a chlorinated intermediate. We do not know enough to improvise disposal or neutralization.”
“So no disposal.”
“No altered stock, no opened production vessels, no drains, no heat. If Theon can safely take a sealed reference sample, he does. Otherwise we photograph labels, copy the safety documentation, and leave it where it is.”
“And a spill?”
“We use the site’s documented emergency procedure or evacuate. We do not guess at chemistry because a report says chlorinated.”
Raphael’s expression suggests I have given the only acceptable answer. “Good.”
Marcus brings up the county plans. “One possible service entry on the north side. It predates the current tenant and does not appear on the latest commercial filing.”
“Possible,” Damon says. “Dominic verifies it in person.”
“I will,” Dominic says.
“Communications,” Nikolai says.